Preconception or gestationally induced diabetes increases morbidities and elevates long-term cardiovascular disease risks in women and their children. Spontaneously hyperglycemic (d)-NOD/ShiLtJ female mice, a type 1 diabetes model, develop bradycardia and hypotension after midpregnancy compared with normoglycemic, age-and gestational day (GD)-matched control (c-NOD) females. We hypothesized that onset of the placental circulation at GD 9-10 and rapid fetal growth from GD 14 correlate with aberrant hemodynamic outcomes in d-NOD females. To develop further gestational time-course correlations between maternal cardiac and renal parameters, high-frequency ultrasonography was applied to d-and c-NOD mice (virgin and at GD 8-16). Cardiac output and left ventricular (LV) mass increased in c-NOD but not in d-NOD mice. Ultrasound and postmortem histopathology showed overall greater LV dilation in d-NOD than in c-NOD mice at mid to late gestation. These changes suggest blunted remodeling and altered functional adaptation of d-NOD hearts. Umbilical cord ultrasounds revealed lower fetal heart rates from GD 12 and lower umbilical
INTRODUCTION
Preconception and gestational diabetes are common complications of human pregnancy, occurring in from 2% to 9% of pregnancies [1] . Both forms of diabetes increase maternal and fetal/neonatal morbidities [2, 3] . Because cardiovascular (CV) disease is strongly associated with diabetes [4] and pregnancy places enormous circulatory demands on women, it is not surprising that circulatory issues occur during and following diabetic pregnancies. Normal pregnancy is regarded as a CV ''stress test'' [5] , in which reversible increases in blood volume (30%-40%) [6] , heart rate (20%-30%) [7] , cardiac output (CO) (30%-60%), and cardiac hypertrophy (5%-10% increase in mass) [8] occur. Normally, these adaptive changes do not lead to increased blood pressure; instead, mean arterial pressure (MAP) declines or remains stable over the course of gestation. This seemingly paradoxical outcome is attributed to systemic vasodilatation and vascular remodeling [9] . In women with diabetes, circulatory adaptations to pregnancy may be incomplete or not fully reversed postpartum, causing persistent or subsequent changes that increase risk for CV diseases. Elevated postpartum risks for heart failure, coronary heart disease, and stroke are reported [10] [11] [12] [13] [14] . Because diabetes itself exacerbates CV disease progression [13, 14] , it is surprising that limited information is available concerning the functional and structural cardiac changes that occur in the pregnant female with diabetes.
In contrast, the impact of maternal glycemic control on fetal and offspring health is well studied. For example, even with good glycemic control, increased incidences of macrosomia [15] , intrauterine growth restriction (IUGR) [15] , congenital heart defects [15] , myocardial hypertrophy [15, 16] , and death are reported in fetuses of women with diabetes [15, 16] . Outcomes are more severe when glycemic control is suboptimal. Echocardiography is an effective clinical tool for assessing fetal well-being, developmental anomalies, or distress [17, 18] . Postnatally, growth and development of offspring from diabetic gestations are accompanied by more CV events, obesity, diabetes, hypertension, and metabolic syndrome [2, 11, 19] .
The spontaneously diabetic NOD/ShiLtJ (d-NOD) mouse is widely used to model pathogenesis of CV disease in type 1 diabetes [3, [20] [21] [22] . Female NOD mice undergo spontaneous, selective destruction of the pancreatic islet cells from 12-30 wk of age (later in males). Gradually, 90%-100% of females turn hyperglycemic by 30 wk of age. Before pancreatic islet cell destruction, animals are normoglycemic. This enables studies using normoglycemic littermates as age-matched controls when the glycemic index is closely monitored. Pregnant d-NOD females were studied by continuously monitored radiotelemetry in a nonanesthetized state, which showed normal hemodynamic parameters until midpregnancy. The mice then became proteinuric and hypotensive in comparison to gestational day (GD)-matched normoglycemic (c)-NOD female mice and had steadily declining MAP until parturition [20] . In addition to this unusual CV adaptation, fetal pathologies resembling those in human diabetic gestations have been reported [20] . Fetal neural tube and congenital cardiac defects are reported as the most frequent pathologies in human pregnancies complicated by pregestational diabetes [23] . Similarly, these defects are observed at high frequency in diabetic mouse pregnancies [20] . The timing of the discordance in MAP between d-NOD and c-NOD mice [20] coincides with developmental opening of the mouse uteroplacental circulation (GD 9-10 [24] ).
The hypothesis of the present study is that functional and structural cardiac responses to the physiological demands of mid to late pregnancy do not progress normally in d-NOD females. Demands such as the acute circulatory expansion resulting from onset of the uteroplacental circulation, and subsequent circulatory demands resulting from rapid fetal growth occur, within this time frame and provide the rationale for studying mid to late gestation. To address this hypothesis, high-frequency ultrasonography was employed to monitor maternal cardiac and renal function and structure before conception and between GD 8 and GD 16 in d-NOD and c-NOD mice. Postmortem assessments of maternal hearts and kidneys were also conducted. Fetal assessments were made by ultrasound examination of umbilical cord parameters between GD 10 and GD 16. Progressive, atypical adaptation of maternal and fetal circulations was documented in d-NOD pregnancies during mid to late gestation.
MATERIALS AND METHODS

Animal Use
The NOD/ShiLtJ (NOD) mice (age, 6-8 wk) were obtained from The Jackson Laboratory. Blood glucose was quantified weekly in tail vein samples using OneTouch Ultra 2 monitors and test strips (LifeScan). Glucose values were considered to be normoglycemic at 9.9 mmol/L or less, prediabetic at between 10.0 and 14.9 mmol/L, and hyperglycemic at 15.0 mmol/L or greater. When a reading of 15.0 mmol/L or greater was obtained, daily blood glucose monitoring was employed to confirm the finding. Three consecutive days of hyperglycemic readings were used to define a mouse as diabetic. Once defined as diabetic, the d-NOD females were immediately age-matched to a c-NOD female, and both were paired with normoglycemic NOD males for breeding. Age of the d-NOD females studied was 18.1 6 0.7 wk (mean 6 SEM), with a range of 13-24 wk; age of the c-NOD females studied was 17.4 6 0.7 wk, with a range of 12-21 wk. Detection of a copulation plug was considered to be GD 0. Diabetic females received supplementary care, including moist chow, daily health checks, and twice-weekly body weight measurement to ensure stability. Glucose levels were measured before euthanasia to ensure a diabetic state had been maintained throughout pregnancy. Subcutaneous fluid (lactated Ringer's solution, 1 ml) was administered daily at signs of dehydration. Animal usage was conducted in accordance with the Society for the Study of Reproduction's specific guidelines and standards and under protocols approved by the Queen's University Animal Care Committee and in accordance with the Canadian Council on Animal Care's Guide to the Care and Use of Experimental Animals.
Ultrasonography
Females were imaged by ultrasound before mating or at GD 8, 10, 12, 14, or 16 using a Vevo 770 High-Frequency In Vivo Micro-Imaging System (VisualSonics). Three d-NOD and three c-NOD pregnancies were used per GD (n ¼ 30 pregnant and 6 virgin females scanned). Females were anesthetized with inhaled isofluorane (Pharmaceutical Partners of Canada, Inc.), placed on the handling platform, and had their limbs fixed to electrode plates using adhesive tape (Transpore; 3M) to enable monitoring of cardiac activity and respiration. Anesthetic induction used 5% isoflurane in oxygen until the animals were inactive and moved to the handling platform. Anesthesia was then was maintained at between 1.5% and 2% isoflurane in oxygen. Heart rate was used as an indicator for depth of anesthesia and to ensure that the lightest effective anesthetic depth was maintained. Depilatory cream (Nair; Church & Dwight Co., Inc.) was used to remove fur over the ventral thorax, abdomen, and pelvis. Warmed, ultrasound-conducting gel (EcoGel 100; ECO-MED Pharmaceuticals) was placed between the area of interest and the ultrasound scanning head. Cardiac scans were conducted on the adult females using a VisualSonics 707B, 30-MHz transducer to collect a left ventricular (LV) shortaxis M-mode cine loop at a midpapillary level. Cardiac measurements were taken from this cine loop postacquisition. Analyses included LV trace, LV inner and outer diameter, LV anterior and posterior wall thickness, and LV chamber size. Vevo 770 software used these measures to calculate CO, stroke volume (SV), ejection fraction, fractional shortening (FS), LV diameter at diastole and systole, LV volume at diastole and systole, and LV mass. After completion of the cardiac scan, left and right renal scans were performed using the VisualSonics 704, 40-MHz transducer. B-mode was used to visualize each kidney and its respective renal artery and renal vein. Pulsed-wave (PW) Doppler signal was obtained for left and right renal arteries. Postacquisition measures were performed on peak systolic and end-diastolic blood flow velocities. These values were used to determine renal resistance index (RI), calculated as (peak systolic flow velocity À end-diastolic flow velocity)/peak systolic flow velocity. Then, for each pregnant female, a minimum of three fetuses were located, and the PW Doppler signals from the fetal umbilical arteries were recorded with an angle of insonation of 60 degrees or less (angle correction was not performed). Nonviable fetuses were observed during some scans but were not used for recordings or analyses. Postacquisition measurements for umbilical artery calculations included peak systolic blood flow velocities and fetal heart rate.
Histological Analyses
Upon completion of the ultrasound examination, mice were euthanized by an overdose of sodium pentobarbital (50 mg/kg; Ceva Sante Animale) and exsanguinated via cardiac puncture. Hearts and kidneys were dissected and immersion-fixed in 4% neutral-buffered paraformaldahyde (Sigma-Aldrich), followed by immersion in 70% ethanol. Tissues were then paraffin-embedded by standard automated processing. Sections from the 36 mice were cut onto slides at a thickness of 3 lm (kidney) or 6 lm (heart), and two nonconsecutive slides per animal were stained using hematoxylin-and-eosin for general histology (heart and kidney), periodic acid-Schiff (PAS) reagent for glycoproteins (kidney), Masson trichrome for collagen deposition (heart), and von Kossa stain for mineral deposition (heart) using published protocols [25, 26] . Heart sections were digitized, and ventricular wall width, interventricular septum length, ventricular lumen, and entire LV area from each heart were traced manually using Zeiss AxioVision software (Carl Zeiss Canada Ltd.). Morphometric analyses of kidneys included eight sequential cortical glomeruli that were assessed under high-power, oil-immersion microscopy from each PAS-stained kidney section. Glomeruli were scored semiquantitatively between 0 and 4 depending on the severity of pathology present (0 ¼ normal; 4 ¼ very severe capillary loop occlusion with hypercellularity) as described elsewhere [27] .
Statistical Analyses
Ultrasound data were analyzed using Prism statistical software (GraphPad Software). Data are presented as the mean 6 SEM and were calculated using n ¼ 3 per group for all maternal data and n ! 9 per group for all fetal data, with a minimum of three fetuses from each of three dams/group. Echocardiographic data were normalized to litter size (values were divided by the number of live pups) to account for differences of litter size within groups. Two-way ANOVA and linear regression were performed for statistical comparisons. Regressions with nonzero slopes were considered to be significant at P 0.05 and used to define a change over time within a group. Differences in changes over time between groups were defined by testing the difference between slopes. Differences were considered to be significant at P 0.05, and nonstatistically significant trends were defined at P 0.15. Bonferroni posttest was used to investigate differences between groups at specific GDs.
RESULTS
General Features of NOD Pregnancies
The d-NOD mice were age-matched to c-NOD mice for breeding. As shown in Table 1 , preconception body weights and GD-matched weights at times of ultrasound scans did not differ between groups. Number of viable pups differed between study pairs but on average were similar between groups (mean (Table 1) .
Cardiac Assessments in d-NOD and c-NOD Mice Before Conception and at GD 8
Echocardiography of mice (virgin and at GD 8) showed no differences between diabetic and control females in any parameter measured (CO, SV, LV diastolic diameter, LV mass, or FS). Histopathology and morphometric measures at these time points also showed no differences. This indicated that heart structure and function were similar in all females AASA ET AL. before mating and in early pregnancy, before opening of the placental circulation.
Maternal Cardiac Adaptations from GD 10 to GD 16
Ultrasound. Cardiac output (a function of SV and heart rate) was normalized to account for variations in litter sizes within groups and over time (Table 1 ). In rats, litter size is reported as positively correlated with CO and negatively correlated with MAP and vascular resistance [28] . Representative parasternal short-axis B-mode and M-mode views of the maternal heart upon which calculations were based are shown in Figure 1 , A and B, respectively. Papillary muscle was used to determine location within the chamber and to maintain consistency across scans. Once normalized, CO was increased in c-NOD mice over the measured gestational time points (P ¼ 0.0246) (Fig. 1C) . This was attributed primarily to increases in SV (Fig. 1D) , because the heart rates were stabilized to the same range at each GD. In contrast to c-NOD mice, d-NOD mice showed no increase in CO or SV over gestation (Fig. 1, C and D). Changes in CO and SV over gestation differed between groups, as shown by the finding of significantly different slopes in regression analysis (P ¼ 0.024 and 0.030, respectively).
Fractional shortening measures the proportion of LV diastolic diameter that is lost in systole and is a surrogate measure for LV systolic function [29] . In normal, nonpregnant humans, the expected FS range is from 27% to 45% [30] . Overall, FS was higher in d-NOD compared to c-NOD mice over the intervals measured (determined by two-way AN-OVA). However, no differences were observed at any particular GD (by Bonferroni posttest), and no effect of gestation was seen in either group (determined by linear regression) (Fig. 1E) . When normalized to heart rate (by dividing FS by heart rate), the same outcome of increased FS in d-NOD compared to c-NOD mice was observed (P ¼ 0.0037, data not shown). LV diastolic diameter, as measured by ultrasound, did not increase in d-NOD mice (P ¼ 0.4158) across mid to late gestation but increased in c-NOD mice (statistically nonzero slope, P ¼ 0.0135). The effect of gestation on LV diastolic diameter differed between d-NOD and c-NOD mice, as demonstrated by a difference in slopes as determined by linear regression (P ¼ 0.017) ( Fig. 2A) . Over the study interval, d-NOD hearts showed no measurable increase in LV mass when adjusted to litter size and calculated from ultrasound measurements. In contrast, LV mass of c-NOD hearts increased over mid to late gestation (Fig. 2B) , reflecting the LV hypertrophy expected in normal pregnancy.
Histopathology. Histopathology of d-NOD left ventricles showed no visible lesions at the gestational time points studied (Fig. 2C) . However, morphometric analyses revealed differences in LV dilation between the d-NOD and c-NOD mice. The d-NOD hearts had a greater ratio of LV lumen to total LV area than control hearts at GD 10-16; analysis at specific GDs revealed differences between groups at GD 14 ( Fig. 2D ). Hearts at GD 8 and from virgin mice were also studied, and no differences were found between groups at either time-point, indicating that changes occur after opening of the uteroplacental circulation.
Renal Analyses
Kidneys play a major role in blood pressure regulation and undergo substantial alteration during normal pregnancy, including increases in size, volume, glomerular filtration rate, and effective renal plasma flow rate [31] . Renal RI, as calculated by ultrasonography, is an indicator for downstream vascular impedance and correlates inversely with changes in renal blood flow expected during normal pregnancy [31] . Bmode and PW Doppler renal scans typical of those used for calculations are illustrated in Figure 3 , A and B, respectively. Renal artery RI did not differ between virgin d-NOD and c-NOD mice or at any gestational time point studied (Fig. 3C) . No structural anomalies were observed in any kidneys via Bmode imaging (Fig. 3A) .
Glomerular changes are the earliest and most frequently observed renal histopathology. Blinded, semiqualitative analysis was performed to assess mesangial matrix expansion and 
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hypercellularity. No quantitative differences in glomerular histology were detected between d-NOD and c-NOD kidneys at any time point studied (Fig. 3, D and E).
Fetal Umbilical Cord Analyses
Umbilical flow rates were not detectable in NOD fetuses before GD 10. From GD 10 onward, however, fetus, placenta, and umbilical cord were easily visualized with B-mode ultrasonography. Figure 4A shows a typical B-mode image 
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of the umbilical cord and placenta of a c-NOD fetus at GD 10, whereas Figure 4B shows a typical PW Doppler scan of the same fetus at GD 10. Pulsatility of the umbilical artery is used to differentiate between the umbilical artery and vein in PW Doppler, with the extent of pulsatility increasing from GD 10 ( Fig. 4B) to GD 16 (Fig. 4C) . Overall analyses between GD 10 and GD 16 showed that fetuses of d-NOD dams had lower umbilical peak and mean flow velocities than fetuses of c-NOD dams (P , 0.0001) (Fig. 4, D and E) . Umbilical artery RI was also lower in fetuses of diabetic dams compared to controls (P ¼ 0.013, data not shown). Differences at specific GDs reached significance at GD 14 and GD 16 (P , 0.001 and 0.05, respectively). In fetuses of c-NOD dams, umbilical artery peak flow velocities increased over mid to late gestation (P ¼ 0.0012). This was blunted in fetuses of d-NOD dams, with a nonstatistically significant trend toward an increase in umbilical flow velocities over mid to late gestation (P ¼ 0.0558). Heart rates in fetuses of both c-NOD and d-NOD pregnancies increased between GD 10 and GD 16 (P , 0.0001 and 0.0051, respectively), but patterns and extent of increases differed between the groups. Fetuses of d-NOD pregnancies had lower heart rates overall than fetuses of c-NOD pregnancies (P ¼ 0.0002). Differences between groups peaked at GD 12 and GD 14 (P , 0.05 and 0.01, respectively) (Fig.  4F) . The onset of lower heart rates in fetuses of d-NOD females at GD 12 and lower umbilical flow velocities at GD 14 suggest that diabetic pregnancies become compromised subsequent to GD 10. This was further exemplified by postmortem enumeration of failed implantation sites with increased fetal loss seen at later GDs (GD 14 and GD 16) in d-NOD compared to c-NOD mice (Fig. 4G) . An asterisk indicates a significant difference (P , 0.05) between groups as determined two-way ANOVA. Increases over gestation within groups were determined by linear regression with a nonzero slope (P , 0.05); nonstatistically significant trends over gestation were defined at P , 0.15. Bar ¼ 500 lm for all panels.
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DISCUSSION
Ultrasound study of d-NOD and c-NOD mice revealed times of onset and progression of functional differences in adaptations of maternal and fetal CV systems that appear to be attributable to hyperglycemia. In pregnant females, diabetes promoted an excessively dilated left ventricle and blunted rise in CO and SV after GD 12. Fetal impairments were clearly present from GD 12 as lower heart rates and at GD 14 as lower umbilical artery flow velocity. These findings suggest either fetal alterations are occurring before the atypical changes in maternal CV adaptation or maternal changes are occurring at GD 10-12 that are not detectable by our study techniques. Completion of fetal and placental development (GD 12) and initiation of rapid fetal growth (GD 14) [32] are the developmental events coinciding with the timing of the atypical responses observed here.
Diabetes alone is known to increase risk for the development of heart failure due to a decrease in myocardial contractile function (diabetic cardiomyopathy). In diabetic mouse models, decreased systolic function has been noted at 1 yr after onset of hyperglycemia [4] . Because the females in the present study were mated at the onset of diabetes and their cardiac ultrasound profiles at mating did not differ from those of c-NOD females, cardiomyopathy was unlikely to have been present at conception. Maternal age differences in time-dependent progression of the diabetic state are present in current study; however, mean ages vary by less than 5%. Previous work by Burke et al. [20] (reported in their supplementary materials) showed that nonpregnant d-NOD females were hemodynamically stable (as measured by continuous radiotelemetry) over the first 13 days following hyperglycemic conversion. Differences in heart rate were only observed in pregnant animals of similar age after midgestation [20] . Another study of nonpregnant female NOD mice (from a different supplier) reported onset of bradycardia at Day 28, their first measurement after diabetic onset [33] . Thus, the cardiac changes seen Within time points, c-NOD flow velocities are increased compared to those of d-NOD mice (P , 0.0001), with peak differences at GD 14 and GD 16 (P , 0.001 and 0.05, respectively). A significant interaction was present between variables (P ¼ 0.047). E) Umbilical artery mean flow velocities. The c-NOD but not d-NOD peak flow velocities increased over the gestational time points measured (P , 0.0001), and differences between groups peaked at GD 14 and GD 16 (P , 0.001 and 0.01, respectively). F) Fetal heart rates. Similar to umbilical flow velocity, c-NOD fetal heart rates increased throughout gestation (P , 0.0001) and overall were higher than those in fetuses of d-NOD dams (P , 0.001). G) Fetal loss as measured by percentage of resorptions to viable pups. Overall, fetal loss was elevated in d-NOD compared to c-NOD mice (P ¼ 0.036). Early GDs for the present study were defined as GD 10 and GD 12; later GDs were defined as GD 14 and GD 16. Differences between groups did not differ at early GDs but reached significance at later GDs (P , 0.05). A minimum of nine fetuses per group were used for all ultrasound data CARDIOVASCULAR CHANGES IN DIABETIC PREGNANCY in the present study by Day 16 after diabetic onset are more likely to be induced by pregnancy rather than solely by diabetes, although the latter cannot be completely discounted. Indeed, the pattern observed here of onset of functional cardiac anomalies after midgestation is consistent with previous work in which the hemodynamic profiles (as measured by radiotelemetry) of d-and c-NOD mice were concordant until GD 10. Subsequently, MAP and heart rate began to diverge, with lower MAP and heart rate in d-NOD compared to control mice [20] . Both studies (present study and [20] ), using very different technical approaches, identify midgestation as a critical period for development of cardiac pathologies during diabetic pregnancy.
Opening of the placental circulation was postulated to pose an acute demand on the maternal CV system that could not be met in hyperglycemic pregnancy. In the present study, CO, used as a measure of cardiac function, followed the expected pattern of gestational increase in c-NOD mice. This suggests that c-NOD hearts are better equipped to meet increased placental and fetal demands. The CO in d-NODs did not increase over this interval, indicating a failure to adapt in a physiological manner. The SV followed the same pattern, with very little difference in P values and a reduction from GD 10 to GD 16 of approximately 29% (compared to a 37% reduction in CO). This indicates that the bradycardia observed in d-NODs is only minimally responsible for the resulting effects on CO and that SV is the major contributor. This effect on SV resembles the blunted increases in CO and LV diastolic diameter reported in pregnant women with diabetes [34] and in CO and SV as reported in a postpartum study of women with previous gestational diabetes [35] . In the latter study, the women with gestational diabetes at 1-4 yr postpartum had markers of endothelial dysfunction (altered flow-mediated dilatation) and subclinical inflammation (elevated interleukin 6, C-reactive protein), both predictive of increased future CV disease risk [35] . The increased FS in d-NOD compared to c-NOD mice is an interesting finding when combined with the observed bradycardia. This phenomenon is not documented in the literature and may be a type of compensation for the decreased heart rate and failure to acquire normal increases in CO. Increased FS may result from decreased heart rate in d-NOD mice. A slower heart rate would allow more time for ventricular filling, resulting in increased ventricular stretch, greater diastolic volume, and increased LV contractile strength, according to the Frank-Starling law of the heart [36] . Postmortem findings reported here support the conclusion drawn from the maternal echocardiography-namely, that the cardiac responses to pregnancy differed between d-NOD and c-NOD females. Development of transient cardiac hypertrophy is expected in normal pregnancy [6] and was observed in c-NOD mice as increasing LV mass over late gestation. This adaptation, which typically reverses postpartum [8] , did not occur in d-NOD hearts. Additionally, d-NOD but not c-NOD hearts showed increasing ratios of lumen area to total ventricular area, suggesting progressive dilation over mid to late gestation. The increased ratio results mainly from increased d-NOD lumen areas (data not shown). Differences in LV diastolic diameter (obtained by M-mode ultrasound), however, are not observed between d-NOD and c-NOD mice. Methodological differences are believed to account for this apparent discrepancy, because the maximally relaxed, intact heart was measured in vivo along a single plane in one dimension using ultrasound whereas fixed hearts, in which some shrinkage would be expected from fixation and processing, were assessed in cut sections by repeated measures in two dimensions.
Myocyte death is an expected step in the pathogenesis of dilated cardiomyopathy [37] . In streptozotocin-induced diabetes, myocyte apoptosis increased in male rat hearts with highest levels reported at Day 3 after drug treatment and declining numbers of apoptotic cells to Day 28 of study [38] . Of interest, myocyte apoptosis was inversely related to blood glucose levels, which increased over the 3-to 28-day posttreatment interval, suggesting that streptozotocin itself contributes to myocyte death. This confounds interpretation of the effects of hyperglycemia on myocyte viability in this model. Because blood glucose values in the treated rats and in d-NOD mice on GD 10 were similar, the apparent lack of histopathology in the mouse hearts of the present study suggests that the more gradual onset of diabetes in NOD mice may be a less pathologic process for myocytes [39] . Further study will be required to define the potential role of cardiac apoptosis in the LV dilation observed in d-NOD mice over late gestation.
Circulatory control involves integrated responses between the CV and renal systems. Neither ultrasound study of the living kidney nor postmortem histopathology revealed gestational differences between d-NOD and c-NOD kidneys. These findings reinforce our conclusion that the heart is a key player in the pathogenesis and development of anomalous CV responses during diabetic pregnancy. Blood vessels and hormones also play important roles in cardiac adaptations to pregnancy, but these were not addressed in our study [40] . Insulin from slow-release implants was not used in the present study, and due to this lack of disease control, greater handling was required of the experimental animals compared with their controls. This included more frequent weighing and subcutaneous fluids at a frequency of up to once per day. Handling stress may also have contributed in a minor way to the observed differences. In addition, the need for anesthetic during ultrasound scanning and individual variations in responses to inhaled anesthetic are limitations of rodent ultrasonography and should be considered when interpreting results.
The impact of diabetes on fetal health was detected by umbilical artery velocimetry as lower d-NOD fetal heart rate and umbilical flow velocity compared to that in c-NOD mice. Both peak and mean umbilical artery flow velocities were assessed to assure that mean flow had not been elevated in d-NOD mice to compensate for their lower peak umbilical flow velocity. The increased incidence of fetal cardiac defects in diabetic pregnancy [2, 23] may contribute to the differences in fetal heart rates observed between d-NOD and c-NOD mice. Umbilical artery velocities are thought to reflect fetoplacental blood flow and to be correlated with total placental volume blood flow, which is decreased in cases of growth-restricted fetuses [41] . Clinically, umbilical artery velocimetry is also useful as a predictive measure of fetal outcome in small-for-gestational-age infants [42] . Recently, others reported no difference in fetal heart rates or fetal aortic flow velocity between normoglycemic and hyperglycemic dams (mated after induction of diabetes using streptozotocin) [43] . Thus, the method by which hyperglycemia develops and its speed of onset may also influence the fetal environment and result in differing fetal CV phenotypes between animal models. The NOD mouse model shows vascular lesions, IUGR, and neural tube and congenital heart defects similar to those of fetuses and offspring of humans with diabetes [13, 18, 20, 21, 23] . Previous study of term pregnancies in d-NOD mice indicated that neonates were smaller than offspring of c-NOD females [20] . In the present study, increased fetal death was observed in d-NOD litters at GD 14-16 compared to c-NOD litters. Thus, ultrasound study of mouse fetuses has predictive value similar to that of clinical ultrasound, and the d-NOD mouse appears to be a strong animal model for advancing current knowledge regarding the effects of hyperglycemia on the maternal CV system during human pregnancy.
Prenatal care and glycemic control of pregnant women with diabetes have been improving in urban regions of developed countries. However, in areas with limited health care access and in studies of unselected populations, increased fetal and maternal morbidities and mortality are still found in diabetic compared to normoglycemic pregnancies. Even in more advanced health care centers, increased prenatal care for women with diabetes compared to routine care resulted in decreased perinatal morbidity and increased maternal quality of life [1] . A study of patients from Britain found that only 7% of women with type 1 diabetes had optimal glycemic control at their first antenatal visit (;9 wk of gestation) [44] . A peak period of sensitivity to lack of glycemic control has been identified as 8-16 wk of human gestation [45] . These data align with the present results and suggest that opening of the uteroplacental circulation (GD 9-10 in mice and ;12 wk of gestation in humans) followed by the onset of rapid fetal growth are the physiological drivers promoting lifelong CV consequences following a diabetic pregnancy. The results of the present study help to stress the importance of optimal glycemic control in diabetic pregnancy as key to the everincreasing coprevalence of diabetes and CV disease in women with postpartum diabetes.
